Literature DB >> 16406920

A stable isotope-mass spectrometric method for measuring human spermatogenesis kinetics in vivo.

L M Misell1, D Holochwost, D Boban, N Santi, S Shefi, M K Hellerstein, P J Turek.   

Abstract

PURPOSE: Currently it is thought to take 60 to 70 days to produce and ejaculate human sperm. This estimate is derived mainly from a single older, descriptive, kinetic analysis of spermatogenesis. We developed a noninvasive method to assess germ cell turnover time accurately in vivo using stable isotope labeling and gas chromatography/mass spectrometry analyses. We confirmed the postulated length of a normal cycle of spermatogenesis.
MATERIALS AND METHODS: A total of 11 men with normal sperm concentrations ingested (2)H(2)O daily for 3 weeks. Semen samples were collected every 2 weeks for up to 90 days. Label incorporation into sperm DNA was quantified by gas chromatography/mass spectrometry, allowing calculation of the percent of new cells present. A cycle of sperm production was determined as the lag time until labeled sperm appeared in the ejaculate.
RESULTS: Labeled sperm were detected after a mean +/- SD of 64 +/- 8 days (range 42 to 76). In 1 subject the time lag was 42 days but it was at least 60 in all other subjects. In most subjects plateau labeling in sperm was not attained. In 2 subjects the rise and fall of the labeling curve was steep and reached greater than 85% new cells, suggesting rapid washout of old sperm in the epididymal reservoir.
CONCLUSIONS: This direct kinetic assessment confirms a course of spermatogenesis that is on the shorter side of traditional estimates based on prior analyses. In addition, the variability observed in healthy men suggests that characteristics such as the epididymal reservoir effect may influence the modeling of in vivo spermatogenesis.

Entities:  

Mesh:

Year:  2006        PMID: 16406920     DOI: 10.1016/S0022-5347(05)00053-4

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  18 in total

Review 1.  The role of deubiquitinating enzymes in spermatogenesis.

Authors:  Bharathi Suresh; Junwon Lee; Seok-Ho Hong; Kye-Seong Kim; Suresh Ramakrishna
Journal:  Cell Mol Life Sci       Date:  2015-09-08       Impact factor: 9.261

Review 2.  FDA-approved drugs that are spermatotoxic in animals and the utility of animal testing for human risk prediction.

Authors:  Elizabeth R Rayburn; Liang Gao; Jiayi Ding; Hongxia Ding; Jun Shao; Haibo Li
Journal:  J Assist Reprod Genet       Date:  2017-10-24       Impact factor: 3.412

Review 3.  Engaging practicing gynecologists in the management of infertile men.

Authors:  Ashok Agarwal; Alaa Hamada; Sandro C Esteves
Journal:  J Obstet Gynaecol India       Date:  2014-11-05

4.  Regulation of Human Spermatogenesis.

Authors:  Filipe Tenorio Lira Neto; Ryan Flannigan; Marc Goldstein
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Determinants of the rate and extent of spermatogenic suppression during hormonal male contraception: an integrated analysis.

Authors:  Peter Y Liu; Ronald S Swerdloff; Bradley D Anawalt; Richard A Anderson; William J Bremner; Joerg Elliesen; Yi-Qun Gu; Wendy M Kersemaekers; Robert I McLachlan; M Cristina Meriggiola; Eberhard Nieschlag; Regine Sitruk-Ware; Kirsten Vogelsong; Xing-Hai Wang; Frederick C W Wu; Michael Zitzmann; David J Handelsman; Christina Wang
Journal:  J Clin Endocrinol Metab       Date:  2008-02-26       Impact factor: 5.958

6.  Isotretinoin administration improves sperm production in men with infertility from oligoasthenozoospermia: a pilot study.

Authors:  J K Amory; K A Ostrowski; J R Gannon; K Berkseth; F Stevison; N Isoherranen; C H Muller; T Walsh
Journal:  Andrology       Date:  2017-10-05       Impact factor: 3.842

Review 7.  Sperm DNA fragmentation testing: Summary evidence and clinical practice recommendations.

Authors:  Sandro C Esteves; Armand Zini; Robert Matthew Coward; Donald P Evenson; Jaime Gosálvez; Sheena E M Lewis; Rakesh Sharma; Peter Humaidan
Journal:  Andrologia       Date:  2020-10-27       Impact factor: 2.775

8.  Birth outcomes in newborns fathered by men with multiple sclerosis exposed to disease-modifying drugs.

Authors:  Ellen Lu; Feng Zhu; Yinshan Zhao; Mia van der Kop; Anne Synnes; Leanne Dahlgren; A Dessa Sadovnick; Anthony Traboulsee; Helen Tremlett
Journal:  CNS Drugs       Date:  2014-05       Impact factor: 5.749

Review 9.  Male infertility due to testicular disorders.

Authors:  Aditi Sharma; Suks Minhas; Waljit S Dhillo; Channa N Jayasena
Journal:  J Clin Endocrinol Metab       Date:  2021-01-23       Impact factor: 5.958

Review 10.  Hypogonadotropic hypogonadism revisited.

Authors:  Renato Fraietta; Daniel Suslik Zylberstejn; Sandro C Esteves
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.